Clinical Trial Update: Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata [Phase 2, Phase 3]

View source ↗

Summary

Phase II/Phase III randomized bilateral trial of topical Targretin Gel 1% for alopecia areata has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Topical Targretin Gel 1% (bexarotene)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Alopecia Areata | Phase 2, Phase 3 | Status: COMPLETED